These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 33155847)

  • 1. Drospirenone: a Latin American perspective for oestrogen-free oral contraception.
    Sales Vieira C; Celis C; Galán G; Hernández L; Díaz I; López J
    Eur J Contracept Reprod Health Care; 2021 Feb; 26(1):73-78. PubMed ID: 33155847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An open-label, multicenter study to evaluate Yasmin, a low-dose combination oral contraceptive containing drospirenone, a new progestogen.
    Parsey KS; Pong A
    Contraception; 2000 Feb; 61(2):105-11. PubMed ID: 10802275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drospirenone/ethinylestradiol 3mg/20microg (24/4 day regimen): a review of its use in contraception, premenstrual dysphoric disorder and moderate acne vulgaris.
    Fenton C; Wellington K; Moen MD; Robinson DM
    Drugs; 2007; 67(12):1749-65. PubMed ID: 17683173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives].
    Cianci A; De Leo V
    Minerva Ginecol; 2007 Aug; 59(4):415-25. PubMed ID: 17923832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drospirenone 4 mg-only pill (DOP) in 24+4 regimen: a new option for oral contraception.
    Chiara Del Savio M; De Fata R; Facchinetti F; Grandi G
    Expert Rev Clin Pharmacol; 2020 Jul; 13(7):685-694. PubMed ID: 32538188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drospirenone: a novel progestin.
    Rapkin AJ; Winer SA
    Expert Opin Pharmacother; 2007 May; 8(7):989-99. PubMed ID: 17472544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drospirenone in combination with estrogens: for contraception and hormone replacement therapy.
    Oelkers WH
    Climacteric; 2005 Oct; 8 Suppl 3():19-27. PubMed ID: 16203652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001-9.
    Lidegaard Ø; Nielsen LH; Skovlund CW; Skjeldestad FE; Løkkegaard E
    BMJ; 2011 Oct; 343():d6423. PubMed ID: 22027398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicenter, phase III trials on the contraceptive efficacy, tolerability and safety of a new drospirenone-only pill.
    Palacios S; Colli E; Regidor PA
    Acta Obstet Gynecol Scand; 2019 Dec; 98(12):1549-1557. PubMed ID: 31321765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drospirenone-only oral contraceptive: results from a multicenter noncomparative trial of efficacy, safety and tolerability.
    Archer DF; Ahrendt HJ; Drouin D
    Contraception; 2015 Nov; 92(5):439-44. PubMed ID: 26232513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The efficiency of oral contraception containing drospirenone in treating symptoms of premenstrual syndrome or premenstrual dysphoric disorder in gyneacology practice].
    Svojanovská K
    Ceska Gynekol; 2010 Oct; 75(5):474-80. PubMed ID: 21374928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oestrogen-free oral contraception with a 4 mg drospirenone-only pill: new data and a review of the literature.
    Palacios S; Regidor PA; Colli E; Skouby SO; Apter D; Roemer T; Egarter C; Nappi RE; Skřivánek A; Jakimiuk AJ; Weyers S; Ács N; Elia D; Gemzell Danielsson K; Bitzer J
    Eur J Contracept Reprod Health Care; 2020 Jun; 25(3):221-227. PubMed ID: 32312141
    [No Abstract]   [Full Text] [Related]  

  • 13. Drospirenone--a new progestogen with antimineralocorticoid activity, resembling natural progesterone.
    Oelkers W
    Eur J Contracept Reprod Health Care; 2000 Dec; 5 Suppl 3():17-24. PubMed ID: 11246598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of a new oral contraceptive containing an antimineralocorticoid progestogen, drospirenone, on the renin-aldosterone system, body weight, blood pressure, glucose tolerance, and lipid metabolism.
    Oelkers W; Foidart JM; Dombrovicz N; Welter A; Heithecker R
    J Clin Endocrinol Metab; 1995 Jun; 80(6):1816-21. PubMed ID: 7775629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drospirenone for oral contraception and hormone replacement therapy: are its cardiovascular risks and benefits the same as other progestogens?
    Motivala A; Pitt B
    Drugs; 2007; 67(5):647-55. PubMed ID: 17385938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The novel progestin drospirenone and its natural counterpart progesterone: biochemical profile and antiandrogenic potential.
    Fuhrmann U; Krattenmacher R; Slater EP; Fritzemeier KH
    Contraception; 1996 Oct; 54(4):243-51. PubMed ID: 8922878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drospirenone (Slynd) - a new progestin-only oral contraceptive.
    Med Lett Drugs Ther; 2020 Feb; 62(1591):18-19. PubMed ID: 32022787
    [No Abstract]   [Full Text] [Related]  

  • 18. Drospirenone: a novel progestogen used as an oral contraceptive without an estrogen component.
    Paton DM
    Drugs Today (Barc); 2020 May; 56(5):321-328. PubMed ID: 32406879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drospirenone: a novel progestogen with antimineralocorticoid and antiandrogenic activity. Pharmacological characterization in animal models.
    Muhn P; Krattenmacher R; Beier S; Elger W; Schillinger E
    Contraception; 1995 Feb; 51(2):99-110. PubMed ID: 7750297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drospirenone/ethinyl estradiol.
    Rapkin AJ; Sorger SN; Winer SA
    Drugs Today (Barc); 2008 Feb; 44(2):133-45. PubMed ID: 18389090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.